WHO ICTRP trial
A Prospective Randomized Phase III Trial of Maintenance Pemetrexed versus…
KCT0004751 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0004751 |
|---|---|
| Public title | A Prospective Randomized Phase III Trial of Maintenance Pemetrexed versus Observation in Patients with Recurrent or Metastatic Urothelial Carcinoma who completed first line platinum-based chemotherapy without disease progression |
| Scientific title | A Prospective Randomized Phase III Trial of Maintenance Pemetrexed versus Observation in Patients with Recurrent or Metastatic Urothelial Carcinoma who completed first line platinum-based chemotherapy without disease progression |
| Primary sponsor | Asan Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug : pemetrexed arm_pemetrexed, 500mg/m2, Q3weeks, up to 16cycle, Intravenous observation arm_ observation without chemotherapy. |
| Registration date | Feb 20, 2020 |
| Target size | 156 |
| Secondary IDs | NCT03193788 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: